EBMT consensus guidelines for children at high risk of SOS/VOD after haematopoietic stem cell transplantation consider defibrotide prophylaxis justified, despite EMA advice against it, and provide a weighted high-risk scoring system to guide its use.
Guideline
Corbacioglu et al. Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT)